Easton Pharmaceuticals, Inc. (EAPH)

[wjb007]

BUY EAPH; Easton Pharmaceuticals EAPH is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. EAPH previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. EAPH has partnered with BMV Medica and together own the exclusive distribution in Mexico and Latin America for patented women’s diagnostic products and two generic cancer drugs. EAPH has made additional investments into AMFIL Technologies, a company involved in the medical marijuana and other industries, and EAPH as well, also has invested via advancing funds towards another Canadian medical marijuana initiative. The EAPH company’s gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs and Cannabidiol extracts.